EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium

Kay Htaik iD, Lenka A Vodstrcil, Erica L Plummer, Laura G Matthews, Ivette Aguirre, Eric P F Chow, Christopher K Fairley, Catriona S Bradshaw

Journal of Antimicrobial Chemotherapy · 01.07.2025 · 80 (7) · 1878-1884

DOI: 10.1093/jac/dkaf142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 22.05.2025. Verfasst von Kay Htaik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Metronidazole, Mycoplasma Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government Research Training Program, Scholarship and Research Entry Scholarship Royal Australasian College of Physicians, Australian NHMRC Leadership Investigator Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Curing Mycoplasma genitalium is challenging in the context of rising antimicrobial resistance and limited therapeutic options. There is an urgent need for globally relevant and effective treatment options using readily available and affordable agents. From September 2021 to August 2024 at Melbourne Sexual Health Centre, we prospectively evaluated microbial cure and tolerability of oral minocycline 100 mg combined with metronidazole 400 mg (twice daily for 14 days) for individuals with macrolide-resistant M. genitalium in whom fluroquinolones had failed or were not advised.

Methods

Microbial cure was defined as a negative test of cure (TOC) using transcription-mediated amplification 14–90 days after completing the regimen. The proportion cured and 95% confidence intervals (CIs) were calculated. Data on side effects and adherence were collected at TOC visits.

Results

Microbial cure in patients receiving the combination regimen was 80.8% (95% CI: 71.9–87.8%). Cure in those who had received preceding doxycycline was 90.3% (n = 28/31, 95% CI: 74.2–98.0%) compared to 76.7% (n = 56/73, 95% CI: 65.4–85.8%) in those who had not, P = 0.172. Central nervous system and gastrointestinal side effects were commonly reported.

Conclusions

Minocycline with metronidazole cured 80% of macrolide-resistant infections in this cohort. Cure may be enhanced by the use of doxycycline before the combination regimen but larger studies are needed. Given limited options for treating resistant M. genitalium infections, the combined minocycline and metronidazole regimen may represent a promising option where no alternative drugs are available, or quinolones are contraindicated. Clinicians should be aware of and discuss side effects with patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumMetronidazoleMycoplasma InfectionsAnti-Bacterial AgentsMinocyclineMacrolidesHumansAdultMaleFemaleProspective StudiesDrug Therapy, CombinationMiddle AgedDrug Resistance, BacterialTreatment OutcomeYoung Adult

Substanzen

MetronidazoleAnti-Bacterial AgentsMinocyclineMacrolides

Autor:innen und Institutionen

  • Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
  • School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Kay Htaik

Förderung

  • Australian Government Research Training Program
  • Scholarship and Research Entry Scholarship Royal Australasian College of Physicians
  • Australian NHMRC Leadership Investigator Grants
  • NHMRC Emerging Leadership Investigator Grant

Zitieren

APA

Htaik, K., Vodstrcil, L. A., Plummer, E. L., Matthews, L. G., Aguirre, I., Chow, E. P. F., Fairley, C. K., & Bradshaw, C. S. (2025). Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium. Journal of Antimicrobial Chemotherapy, 80(7), 1878-1884. https://doi.org/10.1093/jac/dkaf142

Vancouver

Htaik K, Vodstrcil LA, Plummer EL, Matthews LG, Aguirre I, Chow EPF, et al. Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium. Journal of Antimicrobial Chemotherapy. 2025;80(7):1878-1884. doi:10.1093/jac/dkaf142

BibTeX
@article{Htaik2025,
  author = {Htaik, Kay and Vodstrcil, Lenka A and Plummer, Erica L and Matthews, Laura G and Aguirre, Ivette and Chow, Eric P F and Fairley, Christopher K and Bradshaw, Catriona S},
  title = {Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {7},
  pages = {1878--1884},
  doi = {10.1093/jac/dkaf142}
}
Kostenlos starten →